Zovirax

ACYCLOVIR TOPICAL HUMAN PRESCRIPTION DRUG

Zovirax is an FDA drug label for the active ingredient ACYCLOVIR manufactured by Bausch Health US, LLC administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20210201.

Generic name
ACYCLOVIR
Manufacturer
Bausch Health US, LLC
Product type
HUMAN PRESCRIPTION DRUG
Route
TOPICAL
Dosage form
N/A
NDC
0187-0994
Application
NDA021478
Label effective
20210201

About this product

Zovirax is an FDA-registered drug product whose active ingredient is ACYCLOVIR. It is labelled by Bausch Health US, LLC taken by topical and marketed as a human prescription drug product. Identifiers on file: NDC 0187-0994, application NDA021478, label effective 20210201. It is one of 70 FDA drug label records sharing the active ingredient ACYCLOVIR. This page reproduces the FDA-approved label text so you can check what a product is, who makes it and how it is supplied before discussing it with a pharmacist or prescriber.

What it is used for

Across FDA labelling, products containing ACYCLOVIR are most often described in connection with: zovirax cream, herpes simplex, virus hsv, deoxynucleoside analogue, dna polymerase, inhibitor indicated, treatment recurrent, labialis cold. Wording differs between labels, and the full indications section on this page takes precedence when it is present.

Indications & Usage

1 INDICATIONS AND USAGE ZOVIRAX Cream is a herpes simplex virus (HSV) deoxynucleoside analogue DNA polymerase inhibitor indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of age and older. ZOVIRAX Cream is a herpes simplex virus (HSV) deoxynucleoside analogue DNA polymerase inhibitor indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of age and older. ( 1 )

Dosage & Administration

2 DOSAGE AND ADMINISTRATION ZOVIRAX Cream should be applied 5 times per day for 4 days. Therapy should be initiated as early as possible following the onset of signs or symptoms of herpes labialis, i.e. during the prodrome or when lesions appear. For adolescents 12 years of age and older, the dosage is the same as in adults. • Apply 5 times a day for 4 days. ( 2 ) • Administer immediately following the onset of cold sore lesions. ( 2 )

Contraindications

4 CONTRAINDICATIONS ZOVIRAX Cream is contraindicated in patients with known hypersensitivity to acyclovir, valacyclovir, or any component of the formulation. • ZOVIRAX Cream is contraindicated in patients with known hypersensitivity to acyclovir, valacyclovir or any component of the formulation. ( 4 )

Adverse Reactions

6 ADVERSE REACTIONS • The most common adverse reactions reported were local skin reactions at the application site. ( 6.1 ) • Angioedema, anaphylaxis, contact dermatitis and eczema have been reported. ( 6.2 ) To report SUSPECTED ADVERSE REACTIONS, contact Bausch Health US, LLC at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug, and may not reflect the rates observed in clinical practice. In five double-blind, placebo-controlled trials, 1124 patients were treated with ZOVIRAX Cream and 1161 with placebo (vehicle) cream. Local application site reactions were reported by 5% of patients receiving ZOVIRAX Cream and 4% of patients receiving placebo. The most common adverse reactions at the site of topical application were dry lips, desquamation, dryness of skin, cracked lips, burning skin, pruritus, flakiness of skin, and stinging on skin; each adverse reaction occurred in less than 1% of patients receiving ZOVIRAX Cream and placebo. Three patients on ZOVIRAX Cream and one patient on placebo discontinued treatment due to an adverse event. An additional study, enrolling 22 healthy adults, was conducted to evaluate the dermal tolerance of ZOVIRAX Cream compared with vehicle using single occluded and semi-occluded patch testing methodology. Both ZOVIRAX Cream and placebo showed a high and cumulative irritation potential. Another study, enrolling 251 healthy adults, was conducted to evaluate the contact sensitization potential of ZOVIRAX Cream using repeat insult patch testing methodology. Of 202 evaluable subjects, possible cutaneous sensitization reactions were observed in the same 4 (2%) subjects with both ZOVIRAX Cream and placebo, and these reactions to both ZOVIRAX Cream and placebo were confirmed in 3 subjects upon rechallenge. The sensitizing ingredient(s) has not been identified. The safety profile in patients 12 to 17 years of age was similar to that observed in adults. 6.2 Postmarketing Experience In addition to adverse events reported from clinical trials, the following events have been identified during postapproval use of acyclovir cream. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. These events have been chosen for inclusion due to a combination of their seriousness, frequency of reporting, or potential causal connection to acyclovir cream. General: Angioedema, anaphylaxis. Skin: Contact dermatitis, eczema.

More products with the same ingredient

ACYCLOVIR

ACYCLOVIR

Cardinal Health 107, LLC View label

ACYCLOVIR

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. View label

ACYCLOVIR

Major Pharmaceuticals View label

ACYCLOVIR

Proficient Rx LP View label

ACYCLOVIR

Solco Healthcare US, LLC View label

ACYCLOVIR

Alembic Pharmaceuticals Inc. View label

ACYCLOVIR

REMEDYREPACK INC. View label

ACYCLOVIR

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. View label

How products containing ACYCLOVIR compare

FDA lists 70 drug label records with ACYCLOVIR as the active ingredient. The most common dosage forms and the manufacturers with the most records are summarised below; strengths, pack sizes and inactive ingredients can still differ between apparently similar products.

Dosage formProductsManufacturerProducts
— — Proficient Rx LP 11
— — REMEDYREPACK INC. 7
— — Bryant Ranch Prepack 5
— — A-S Medication Solutions 4
— — PD-Rx Pharmaceuticals, Inc. 4

Frequently asked questions

What is Zovirax used for?
1 INDICATIONS AND USAGE ZOVIRAX Cream is a herpes simplex virus (HSV) deoxynucleoside analogue DNA polymerase inhibitor indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of age and older. ZOVIRAX Cream is a herpes simplex virus (HSV) deoxynucleoside analogue DNA polymerase inhibitor indicated for the treatment of recurrent …

Who makes Zovirax?
Bausch Health US, LLC is the labeler of record for Zovirax. 70 FDA label records share the active ingredient ACYCLOVIR, so generic and branded versions may come from different companies; the manufacturer named on your pack is the one that matters for any enquiry.

What form does Zovirax come in?
administered by topical. Strengths and pack sizes vary by label, so compare the NDC on your pack with the identifier listed on this page.

Is Zovirax prescription or over-the-counter?
The FDA label for this product is recorded as human prescription drug. Marketing status can differ between strengths and countries, so check the dispensing rules where you live.

Are there other products containing ACYCLOVIR?
Yes. 70 FDA drug label records list ACYCLOVIR as the active ingredient. Products with the same active ingredient can usually be substituted only when a prescriber or pharmacist confirms it is appropriate.

Has Zovirax been recalled?
No FDA recall record in our database matches this product name or manufacturer. Recall data is updated periodically, so a very recent notice may not appear here yet.

Where does this information come from?
All content is reproduced from FDA Structured Product Labelling data via openFDA. It is provided for identification and reference only and is not medical advice.

This page reproduces FDA Structured Product Labelling data for identification and reference. It is not medical advice, does not diagnose or treat any condition, and does not sell or price any medicine.